This company has been marked as potentially delisted and may not be actively trading. Acer Therapeutics (ACER) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Acer Therapeutics Short Interest DataAcer Therapeutics (ACER) has a short interest of 524,900 shares, representing 13.78% of the float (the number of shares available for trading by the public). This marks a 6.34% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest524,900 sharesPrevious Short Interest493,600 sharesChange Vs. Previous Month+6.34%Dollar Volume Sold Short$441.02 thousandShort Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2023Outstanding Shares24,460,000 sharesFloat Size3,810,000 sharesShort Percent of Float13.78%Today's Trading Volume574,675 sharesAverage Trading Volume0 sharesToday's Volume Vs. Average∞ Short Selling Acer Therapeutics? Sign up to receive the latest short interest report for Acer Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACER Short Interest Over TimeACER Days to Cover Over TimeACER Percentage of Float Shorted Over Time Acer Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2023524,900 shares $441.02 thousand +6.3%13.8%0.2 $0.84 10/15/2023493,600 shares $375.14 thousand -6.7%N/A0.2 $0.76 9/30/2023529,100 shares $431.22 thousand -41.1%N/A0.2 $0.82 9/15/2023898,100 shares $776.14 thousand +25.2%N/A0.4 $0.86 8/31/2023717,600 shares $918.53 thousand -20.7%N/A0.3 $1.28 8/15/2023905,400 shares $693.08 thousand +2.4%N/A6.1 $0.77 7/31/2023884,100 shares $769.17 thousand -2.7%N/A5.3 $0.87 7/15/2023908,200 shares $735.64 thousand +1.3%N/A5.1 $0.81 6/30/2023896,400 shares $827.74 thousand +14.7%N/A4.5 $0.92 6/15/2023781,500 shares $681.47 thousand -3.7%N/A3.6 $0.87 Get the Latest News and Ratings for ACER and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acer Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/31/2023811,900 shares $722.59 thousand -18.4%N/A2.3 $0.89 5/15/2023994,500 shares $751.74 thousand -9.6%N/A3.2 $0.76 4/30/20231,100,000 shares $965.36 thousand -6.8%N/A3.6 $0.88 4/15/20231,180,000 shares $1.35 million -7.1%N/A3.6 $1.14 3/31/20231,270,000 shares $963.30 thousand +275.5%N/A3 $0.76 3/15/2023338,200 shares $541.12 thousand +14.4%N/A0.6 $1.60 2/28/2023295,600 shares $600.07 thousand +3.4%N/A0.5 $2.03 2/15/2023285,800 shares $597.32 thousand -42.6%N/A0.5 $2.09 1/31/2023498,300 shares $1.16 million +85.7%N/A0.8 $2.32 1/15/2023268,400 shares $805.20 thousand -36.7%2.1%0.5 $3.00 12/30/2022424,300 shares $1.06 million -35.5%3.3%0.9 $2.51 12/15/2022657,800 shares $2.12 million +932.7%5.1%1.8 $3.22 11/30/202263,700 shares $80.90 thousand +14.8%0.5%0.6 $1.27 11/15/202255,500 shares $67.16 thousand -35.5%0.4%0.8 $1.21 10/31/202286,100 shares $109.35 thousand +44.5%0.6%0.9 $1.27 10/15/202259,600 shares $72.71 thousand -23.3%0.4%0.6 $1.22 9/30/202277,700 shares $108.00 thousand -2.0%0.6%0.8 $1.39 9/15/202279,300 shares $118.16 thousand +19.3%0.6%0.7 $1.49 8/31/202266,500 shares $89.78 thousand -18.8%0.5%0.5 $1.35 8/15/202281,900 shares $124.49 thousand -49.2%2.2%0.6 $1.52 7/31/2022161,300 shares $225.06 thousand +7.0%4.2%1.1 $1.40 7/15/2022150,700 shares $231.19 thousand -7.6%4.0%1 $1.53 6/30/2022163,000 shares $205.38 thousand +49.3%4.3%0.9 $1.26 6/15/2022109,200 shares $197.65 thousand -24.6%2.9%0.2 $1.81 5/31/2022144,900 shares $346.31 thousand -41.0%1.1%0.3 $2.39 5/15/2022245,600 shares $476.46 thousand +313.5%1.9%0.5 $1.94 4/30/202259,400 shares $122.36 thousand -14.5%0.5%0.1 $2.06 4/15/202269,500 shares $159.85 thousand +58.7%0.5%0.2 $2.30 3/31/202243,800 shares $127.02 thousand -51.2%0.4%0.1 $2.90 3/15/202289,700 shares $211.69 thousand -46.9%0.7%1.6 $2.36Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 2/28/2022169,000 shares $419.12 thousand +1.4%1.4%3.2 $2.48 2/15/2022166,600 shares $406.50 thousand -7.0%1.4%3.1 $2.44 1/31/2022179,100 shares $362.68 thousand -9.9%1.5%3.3 $2.03 1/15/2022198,700 shares $439.13 thousand -13.2%1.6%3.1 $2.21 12/31/2021228,900 shares $521.89 thousand -27.1%1.9%3 $2.28 12/15/2021314,000 shares $665.68 thousand +14.5%2.6%1.1 $2.12 11/30/2021274,200 shares $575.82 thousand +1.5%2.3%0.9 $2.10 11/15/2021270,100 shares $648.35 thousand -14.7%2.2%0.9 $2.40 10/29/2021316,500 shares $743.78 thousand -10.5%2.6%1.1 $2.35 10/15/2021353,700 shares $859.49 thousand +139.2%2.9%0.8 $2.43 9/30/2021147,900 shares $378.62 thousand -14.8%1.2%0.3 $2.56 9/15/2021173,600 shares $446.15 thousand -13.5%1.4%0.8 $2.57 8/31/2021200,600 shares $527.58 thousand -37.4%1.7%0.9 $2.63 8/13/2021320,400 shares $784.98 thousand +361.0%2.6%1.4 $2.45 7/30/202169,500 shares $177.92 thousand +53.4%0.6%0.3 $2.56 7/15/202145,300 shares $110.53 thousand -9.2%0.4%0.5 $2.44 6/30/202149,900 shares $142.71 thousand +4.2%0.4%0.5 $2.86 6/15/202147,900 shares $138.91 thousand -64.5%0.4%0.3 $2.90 5/28/2021135,000 shares $395.55 thousand -34.1%1.1%0.2 $2.93 5/14/2021204,700 shares $515.84 thousand -24.4%N/A0.3 $2.52 4/30/2021270,800 shares $801.57 thousand -34.4%N/A0.4 $2.96 4/15/2021412,900 shares $1.19 million +26.3%N/A0.5 $2.87 3/31/2021326,900 shares $974.16 thousand +235.6%N/A0.2 $2.98 3/15/202197,400 shares $332.13 thousand +6.1%N/A0.1 $3.41 2/26/202191,800 shares $291.01 thousand -27.2%N/A0.1 $3.17 2/12/2021126,100 shares $503.14 thousand -52.6%1.3%0.2 $3.99 1/29/2021265,900 shares $1.01 million +28.3%3.1%0.3 $3.79 1/15/2021207,300 shares $592.88 thousand -43.3%2.4%0.3 $2.86 12/31/2020365,800 shares $976.69 thousand -12.1%4.9%2.4 $2.67 12/15/2020416,100 shares $986.16 thousand -16.4%5.6%3 $2.37 11/30/2020497,600 shares $1.29 million +43.0%6.7%4.3 $2.60 11/15/2020348,000 shares $974.40 thousand -35.3%4.8%2.6 $2.80 10/30/2020538,100 shares $1.42 million -2.6%7.6%2 $2.64 10/15/2020552,300 shares $1.56 million +10.1%7.8%1.3 $2.83 9/30/2020501,500 shares $1.44 million +18.1%7.6%1.1 $2.88 9/15/2020424,800 shares $1.05 million -21.9%6.5%0.9 $2.47 ACER Short Interest - Frequently Asked Questions What is Acer Therapeutics' current short interest? Short interest is the volume of Acer Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 524,900 shares of ACER short. 13.78% of Acer Therapeutics' shares are currently sold short. Learn More on Acer Therapeutics' current short interest. What is a good short interest percentage for Acer Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.78% of Acer Therapeutics' floating shares are currently sold short. Is Acer Therapeutics' short interest increasing or decreasing? Acer Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 524,900 shares, an increase of 6.3% from the previous total of 493,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acer Therapeutics' float size? Acer Therapeutics currently has issued a total of 24,460,000 shares. Some of Acer Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acer Therapeutics currently has a public float of 3,810,000 shares. How does Acer Therapeutics' short interest compare to its competitors? 13.78% of Acer Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acer Therapeutics: Actinium Pharmaceuticals, Inc. (3.24%), Eagle Pharmaceuticals, Inc. (0.32%), PyroGenesis Canada Inc. (0.14%), NanoViricides, Inc. (0.26%), Matinas Biopharma Holdings, Inc. (2.90%), AEON Biopharma, Inc. (2.79%), Oragenics, Inc. (0.47%), China Pharma Holdings, Inc. (0.52%), Spruce Biosciences, Inc. (0.22%), Can-Fite BioPharma Ltd. (3.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Corporation ($9.07 billion), T-Mobile US, Inc. ($3.71 billion), Charter Communications, Inc. ($3.51 billion), Occidental Petroleum Corporation ($2.81 billion), lululemon athletica inc. ($2.35 billion), Tractor Supply Company ($2.26 billion), Coinbase Global, Inc. ($1.88 billion), Rivian Automotive, Inc. ($1.71 billion), Celsius Holdings Inc. ($1.67 billion), and Newmont Corporation ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Acer Therapeutics stock? Short selling ACER is an investing strategy that aims to generate trading profit from Acer Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acer Therapeutics? A short squeeze for Acer Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACER, which in turn drives the price of the stock up even further. How often is Acer Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACER, twice per month. The most recent reporting period available is October, 31 2023. More Short Interest Resources from MarketBeat Related Companies ATNM Short Squeeze EGRX Short Squeeze PYRGF Short Squeeze NNVC Short Squeeze MTNB Short Squeeze AEON Short Squeeze OGEN Short Squeeze CPHI Short Squeeze SPRB Short Squeeze CANF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACER) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acer Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acer Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
